NEW YORK (GenomeWeb) – Golden Helix has signed an agreement with PreventionGenetics that allows the latter to implement Golden Helix's VarSeq software into its exome sequencing pipeline.
PreventionGenetics will use the solution to analyze data from an exome sequencing test for clinical diagnostics that the company is preparing to launch in mid-2015. The software streamlines the process of annotating and filtering variants from next-generation sequencing data. It features a simple user interface and scalable architecture with repeatable workflows, tools for note taking and reporting, and filter parameter prototyping.
VarSeq "will allow us to move forward with offering an exome test" by providing tools "to take abundant sequence from exome data and efficiently translate that into molecular diagnoses," Jerry Machado, a clinical molecular geneticist at PreventionGenetics, said in a statement.
Financial and other terms of the agreement were not disclosed.